A randomized, double-blind, placebo-controlled Phase III study of Study Drug versus placebo for patients with advanced gastrointestinal stromal tumors (GIST) who have received prior treatments.
About PRA Health Sciences
We are a global healthcare intelligence partner, consistently ranked among the top CROs and best employers worldwide.
Managing Trials With Multiple Partners
Clinical trials are complex undertakings and whether by necessity or strategic design, an increasing number of trials are now outsourced by pharma…